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Abstract:  The  aim  of  this  manuscript  is  to  describe  how  modern  advances  in  our 
knowledge of viruses and viral evolution can be applied to the fields of disease ecology 
and conservation. We review recent progress in virology and provide examples of how it is 
informing both empirical research in field ecology and applied conservation. We include a 
discussion of needed breakthroughs and ways to bridge communication gaps between the 
field and the lab. In an effort to foster this interdisciplinary effort, we have also included a 
table that lists the definitions of key terms. The importance of understanding the dynamics 
of zoonotic pathogens in their reservoir hosts is emphasized as a tool to both assess risk 
factors  for  spillover  and  to  test  hypotheses  related  to  treatment  and/or  intervention 
strategies.  In  conclusion,  we  highlight  the  need  for  smart  surveillance,  viral  discovery 
efforts  and  predictive  modeling.  A  shift  towards  a  predictive  approach  is  necessary  in 
today‘s  globalized  society  because,  as  the  2009  H1N1  pandemic  demonstrated, 
identification  post-emergence  is  often  too  late  to  prevent  global  spread.  Integrating 
molecular  virology  and  ecological  techniques  will  allow  for  earlier  recognition  of 
potentially dangerous pathogens, ideally before they jump from wildlife reservoirs into 
human or livestock populations and cause serious public health or conservation issues.  
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1. Introduction 
“A thing is right when it tends to preserve the integrity, stability, and beauty of the biotic community. 
It is wrong when it tends otherwise.”—Aldo Leopold 
Our planet is currently experiencing the sixth mass extinction event in history [1]. Although there 
are problems with estimating the total number of extant animal species [2], recent extinction rates are 
thought  to  be  100-  to  1000-times  greater  than  past  rates  determined  from  the  fossil  record.  It  is 
estimated that as many as 140,000 species are perishing each year  [3]. Although habitat loss and 
fragmentation are the main drivers of this high extinction rate, infectious disease also contributes to 
animal population declines either independently, by reducing population size, or through interactions 
with other processes [4,5].  
Indeed, these anthropogenic changes to habitat are also contributing to a second biological crisis: an 
increase in the rate of emerging and re-emerging infectious diseases (EIDs) [6,7]. Of these EIDs, 75% 
are zoonotic (see Table 1 for a definition) [8] and 37% are RNA viruses [9]. The high mutation rate of 
RNA viruses coupled with their ability to recombine and reassort allows for a rapid rate of evolution. 
In turn, this makes them highly adaptable and thus able to both exploit the new hosts and habitats 
afforded by a changing environment, as well as to develop resistance to treatments [10]. Examples of 
zoonotic  RNA  viruses  which  have  emerged  relatively  recently  include  SARS  coronavirus  (SARS 
CoV),  West  Nile  virus  (WNV),  Chikungunya  virus,  the  2009  influenza  A  (H1N1)  and  human 
immunodeficiency virus type 1 (HIV-1) and 2 (HIV-2). Cumulatively, these ailments have claimed 
hundreds of millions of human lives and cost the global economy hundreds of billions of US dollars. 
Among  all  viruses,  HIV-1  causes  the  greatest  amount  of  human  mortality  [11]  and  its 
immunosuppressive  nature  is  facilitating  the  resurgence  of  ―old‖  pathogens  (i.e.,  tuberculosis)  in 
human populations [12]. It is possible that the emergence of HIV is also encouraging cross-species 
transmission  and  that  these  disease  threats  may  have  a  severe,  negative  impact  on  wild  animal 
populations [13]. A multi-disciplinary approach will be necessary to combat the crises of extinction 
and disease emergence because human, ecosystem and animal health are inextricably linked. In recent 
years,  great  advances  have  been  made  in  virology  and  disease  ecology,  particularly  towards 
elucidating  the  mechanisms  behind  the  emergence  and  evolution  of  zoonotic  viruses.  Thus,  it  is 
important  to  review  and  consider  how  advances  in  virology  and  disease  ecology  complement 
each other. 
The roots of ecology date back to Theophrastus in the 4th century B.C. [14]. The concept of food 
chains originated in the 17th century and Darwin and Wallace put forth the theory of evolution in the 
18th century [15], but ecology did not become a prominent field until 1927 when two key advances 
transformed  the  study  into  a  proper  discipline.  In  this  year,  Charles  Elton  published  his  Animal 
Ecology [16] and Kirmack and McKendrick (1927) [17] formulated a model to describe the progress 
of an epidemic in a homogenous population [16,17]. In the 1960s, Rachael Carson‘s Silent Spring Viruses 2011, 3                         
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generated concern for the environment and thrust ecologists into a new political field where preserving 
the integrity of our global ecosystems was the priority [18]. Even so, the Society for Conservation 
Biology  was  not  established  until  1985  [19].  As  a  part  of  this  transition,  ecology  shifted  from  a 
descriptive science to one of prediction, reflecting the hope that ecologists might mitigate changes 
which can have negative impacts upon the ecosystem. Ecologists have branched out into the study of 
parasites and disease as it has become increasingly apparent that parasites are inextricably linked to the 
ecology of their hosts and environments, to the point where they have been a driving force in the 
evolution of sexual reproduction and in the shaping of biodiversity [20,21]. Over the past 30 years, 
disease ecologists have developed the study of parasites and pathogens in the wild. This knowledge 
has been synthesized into mathematical models which describe the dynamic properties of ecosystems 
and predict how parasites and pathogens flow through them. [22,23]. These models are becoming more 
commonly integrated into epidemiological studies that seek to predict outbreaks or periods of time 
when cross-species spillover risk is highest.  
Parallel to this progress, the field of virology, particularly the subfields of molecular virology and 
viral evolution, have also been burgeoning, largely due to advances in technology that have made 
molecular  assays  and  genetic  sequencing  more  accessible  to  a  greater  number  of  scientists.  The 
development  of  high-throughput  sequencing  has  greatly  increased  our  ability  to  efficiently  detect 
known viruses as well as to discover new types of viruses, thereby improving our understanding of 
viral diversity, pathology and evolution. This increased capacity has spawned the development of new 
fields of study. For example, phylodynamics allows researchers to determine the origin of circulating 
viruses in space and time. Mutations among viral strains can be used to investigate interactions among 
host species as well as long-range host movement via corridors and flyways. Phylodynamic analyses 
can also inform livestock management practices, as was the case with Foot and Mouth disease in the 
United Kingdom [24].  
Conducting  viral  surveillance  in  animal  reservoirs  and  invertebrate  vectors  can  help  explain 
circulation within host species; observed patterns of zoonotic transmission; and even allow for the 
prediction of periods of increased risk of zoonotic transmission (e.g., Rift valley fever and rainfall 
[25];  West  Nile  virus  (WNV)  and  American  robin  (Turdus  turdus)  migration  [26];  as  well  as 
hantavirus  in  mice  [27,28]).  Understanding  viral  ecology  in  wildlife  reservoirs  and  identifying  
high-risk human-wildlife interfaces is especially critical in the context of ever increasing globalization, 
whereby  transportation  networks  facilitate  rapid  spread  of  pathogens  well  beyond  bounds  where 
traditional epidemiological methods can be effective [29–31]. The 2009 influenza A (H1N1) pandemic 
spread from the presumptive point of emergence in La Gloria Mexico to New Zealand in just under a 
month [32] while SARS radiated from Guangdong, China to 26 different countries within several 
months [29]. 
The negative impacts of emerging infectious diseases are not limited to humans. Indeed, wildlife 
conservationists  have  documented  several  mass  mortality  events  in  other  animal  species.  Western 
lowland gorillas (Gorilla gorilla gorilla) have been decimated by Ebola virus [33] and an especially 
virulent calicivirus, rabbit hemorrhagic disease virus, spread through both domestic and wild rabbit 
populations,  resulting  in  tens  of  millions  of  deaths  [34].  In  some  instances  the  viruses  have 
attenuated,  while  in  others  the  animal  populations  have  been  brought  to  the  brink  of extinction. 
Importantly,  the  risk  from  disease  to  humans  and  animals  should  not  be  separated.  The  global Viruses 2011, 3                         
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transportation network facilitated the introduction of infected vectors (e.g., mosquitoes) into New York 
and WNV caused both avian and human mortality, and this virus has subsequently spread across the 
United States [26].  
Table 1. Definitions of key terms used in the text. 
Term  Definition 
  Terms from Molecular Genetics & Phylodynamics 
Admixture  The formation of a hybrid population through the mixing of two ancestral, or long-separated, 
populations. 
Bayesian Skyline 
Plot 
A method for estimating historical population dynamics from a sample of sequences without assuming 
a predefined demographic model. 
Coalescent 
Theory 
A mathematical framework which describes the distribution of gene trees in populations. It provides 
mathematical methods for connecting demographic or ecological models with a phylogenetic tree. 
Demography 
Demography is the statistical study of populations. In the field of ecology, demography encompasses 
the study of the size, structure and distribution of populations, and spatial and/or temporal changes in 
them in response to birth, migration, aging and death. However, here we use a more rigid definition of 
demography—as the pattern and rate of population growth. 
Effective 
population size 
(Ne) 
The number of breeding individuals in an idealized population that would show the same amount of 
dispersion of allele frequencies under random genetic drift, or the same amount of inbreeding, as the 
natural population under consideration. The analogue of Ne for viruses, the ‗effective number of 
infections‘ is related to the number of infected host individuals and to the number of new transmission 
events [35]. 
Metagenomics  A discipline which uses next-generation sequencing technologies to characterize the entirety of 
genomic material found in environmental samples. 
Molecular Clock 
The molecular clock is derived from the hypothesis that sequence evolution, while random, occurs at 
stable rate such that the time since the divergence of two or more sequences can be estimated. Recent 
‗relaxed molecular clock‘ analysis can account for variation in the rate of sequence evolution through 
time or between lineages. 
Phylogeny  The relations among a set of sequences showing which shares a most recent common ancestor with 
other sequences. 
Phylogeography  The study of the principles and processes governing the geographical distribution of genealogical 
lineages. 
Population 
Structure 
In the field of population genetics, population structure is defined as the absence of random mating 
within a population. This is the definition used here. In ecology, population structure is defined by 
several key parameters including number of individuals in a population, age distribution of 
individuals, probabilities of survival (or mortality), and rates of fecundity. 
Reassortment  A process that occurs in segmented viruses by which one or more segments ‗swap‘ to create a new 
viral genome. This drives the process of antigenic shift in Influenza A viruses. 
Recombination 
The process by which new genotypes are created by the combination of distinct lineages. In sexual 
organisms it occurs during meiotic division, by the exchange of DNA between different chromosomes 
or ‗crossing-over‘. Viral recombination occurs during viral replication and is an important factor in 
viral evolution (for more details see Worobey and Holmes, 1999 [36]). 
Reversion  Mutation of a virus such that it changes ‗back‘ to its wild-type state. 
Terms from Ecology 
Life History 
The timing of an organism‘s schedule of reproduction and death. Species with long life histories, also 
known as ‗K‘ strategists, tend to have low reproductive rates, stable populations, long generation 
times and long lifespans.  
Terms from Disease Ecology 
Aggregation 
Where the parasite population is not randomly distributed among hosts, such that the variance is 
greater than the mean. The macroparasites in a host population are often best described by the negative 
binomial distribution such that a minority of hosts possess the majority of the parasites. 
R0 (Basic 
Reproduction 
Number) 
In the case of viruses and other microparasites, R0 is the average number of secondary infections 
which an infection produces. As such it is a measure of parasite fitness. 
Reservoir Host  A host species that can independently maintain a disease and act as a source of infection to other host 
species. Infection in reservoirs is usually more persistent and less harmful than that of other hosts. 
Zoonotic disease  A disease transmissible from animals to humans or vice versa. Viruses 2011, 3                         
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Globalization,  host  ecology,  host-virus  dynamics,  climate  change,  and  anthropogenic  landscape 
changes  all  contribute  to  the  complexity  of  zoonotic  viral  emergence  and  disease,  and  create 
significant  conservation  and  public  health  challenges.  Comprehensive  and  collaborative  scientific 
approaches that transcend disciplinary boundaries are necessary to address these challenges. It is the 
goal of this paper to review new methods for understanding viral dynamics and illustrate how and 
when these techniques can be used by not only public health officials, but also disease ecologists and 
conservation biologists. 
2. Phylodynamics 
The phylodynamic paradigm, established in 2004 [37], exemplifies the power of a multidisciplinary 
approach.  It  unites  the  ecological  and  evolutionary  study  of  viruses  and  builds  upon  advances  in 
sequencing  technologies  and  coalescent  theory,  by  which  gene  genealogies  are  reconstructed 
backward in time [38]. The analysis of phylogenetic trees enables researchers to address many of the 
primary questions posed by disease ecologists (Figure 1). In some cases this approach can provide an 
estimate of a virus‘s basic reproductive number (R0), which is a measure of parasite fitness [39]. 
Phylodynamics has far-reaching applications for the control of viruses in both human and animal 
populations, in addition to being vital to our understanding of the interconnectedness between them.  
Phylodynamic studies can be used to identify reservoir species as well as defining the spatial and 
temporal origin of emerging infectious diseases [37]. They can also help to elucidate how these viruses 
spread following their emergence [39]. Firstly, chains of viral transmission can be extrapolated from 
the branching topology of phylogenetic trees. One example of the utility of this approach is with rabies 
virus. Rabies causes thousands of human deaths a year in Africa and has been implicated in the decline 
and  local  extinction  of  several  populations  of  African  wild  dog  (Lycaon  pictus)  [40,41].  
Lembo et al. analyzed sequences of rabies virus from the Serengeti, revealing that domestic dogs were 
the reservoir of the virus and that they had transmitted it to other resident carnivore populations on 
repeated occasions [42]. This work has applicability in that it can be used to design efficient and 
effective vaccination strategies, both to alleviate current distress and prevent future outbreaks [40]. 
Secondly, by mapping the geographical origin of each sequence onto the nodes of phylogenetic trees, 
the  geographical  origin  of  a  virus  might  be  identified.  Wallace  et  al.  (2007)  [43]  used  this 
phylogeographic approach to identify Guangdong province, China as the most parsimonious origin of 
highly pathogenic H5N1 strain of avian influenza and to delineate the most likely pathways of viral 
spread [43]. However, a recent Bayesian analysis of this data did not support the conclusion that H5N1 
had dispersed from Guangdong to Indonesia [44]. Instead, the Bayesian analysis suggested it had 
spread  to  Indonesia  from  Guangxi  or  Hunan  in  China.  This  example  demonstrates  that  different 
statistical techniques may yield different conclusions. As yet, neither the Bayesian nor the frequentist 
method is universally considered to be superior and there is much room for improvement as statistical 
phylogeography develops as a field. Phylogeographic tools have also been applied by Walsh et al. 
(2005) [45] to locate the putative origin of the Zaire strain of Ebola virus. In an attempt to resolve the 
controversy over the time of emergence and spreading trajectory of Ebola in the Congo Basin, they 
then used spatial data and two different tests for the impact of selection on the virus genome [45].  
Where  a  virus  is  expanding  in  range,  as  the  Zaire  strain  of  Ebola  virus  appears  to  be,  using  a Viruses 2011, 3                         
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‗landscape genetics‘ approach may help identify geographical barriers to viral spread and help identify 
vulnerable human or wildlife populations lying in the path of infection [46,47].  
Figure  1.  Phylodynamic  techniques.  (a)  A  rooted  molecular  phylogeny  represents  the 
evolutionary relationships between individual viral sequences, as represented by circles. 
These phylogenies may reflect transmission chains, however sampling must be sufficient 
for them to do so, while recombination may obscure ‗true‘ relationships between viral 
sequences.  (b)  Simple  molecular  clock  theory,  predicated  on  the  neutral  theory  of 
molecular evolution [48] assumes that mutation occurs at a constant rate over time, thus the 
time that has elapsed since a pair of virus strains diverged from a common ancestor may be 
quantified.  Methods  that  account  for  differences  in  the  evolutionary  rates  of  different 
strains, and for variation in these rates through time, have been recently developed [49]. 
Here variants represented by thick lines evolve much faster than those represented by thin 
lines. (c) Using a phylogeographic approach, the location at which a sequence was sampled 
may be mapped onto the viral phylogeny and the likely spreading trajectory of the virus 
inferred. While parsimony approaches have been popular, powerful Bayesian methods that 
account for uncertainty of dispersal process and historical phylogeny have been developed 
to reconstruct viral dispersal events [44]. Crosses on the phylogeny represent such viral 
dispersal  events,  in  this  example.  (d)  Coalescent  theory  provides  the  basis  for  many 
phylodynamic  approaches.  Here,  circles  on  the  same  row  represent  temporally 
simultaneous infections. Working back from sampled infections (red circles), lineages can 
be  traced  back  to  the  most  recent  common  ancestor  (black  circle)  via  hypothetical, 
unsampled ancestors (grey circles). The time it takes for sampled lineages to coalesce is 
dependent  on  a  variety  of  variables  (i.e.,  viral  effective  population  size,  population 
structure, selection, stochastic infection die-out and recombination). A variety of methods 
are  available  to  test  for  selection  and  recombination.  Figure  and  legend  adapted  with 
permission  from  Macmillan  Publishers  Ltd:  Nature  (Pybus,  O.G.,  Rambaut,  A. 
Evolutionary analysis of the dynamics of viral infectious disease), copyright (2009) [50].  
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Phylodynamic analyses are not without limitations. Dense and representative sampling at a scale 
equivalent  to  epidemiological  surveys  is  required  to  fulfill  the  potential  of  phylodynamics  for 
understanding epidemics of rapidly-evolving viruses [51]. The construction of phylogenetic trees from 
these viral sequences may be complicated by recombination and, in the case of segmented viruses, 
reassortment  of  viral  genomes  [36].  As  a  result  of  these  processes,  the  genes  on  a  single  viral 
sequence  may  have  very  different  origins  (see  the  discussion  of  the  different  origins  of  the 
hemagglutinin  and  neuraminidase  segments of H5N1 avian  influenza  in  Lemey  et al. 2009  [44]). 
Therefore,  concatenated  analysis  of  multiple  genes  may  be  confounded.  The  ability  to  construct 
phylogenies is further limited by the total viral genetic information available. GenBank is a vast public 
database that contains records of genetic sequences; however, its usefulness is dependent upon the 
willingness and/or ability of individuals and organizations to submit viral sequences. Governments and 
industrial  institutions  may  be  reluctant  to  report  sequences  of  economically  important  viruses  
(i.e.,  avian  influenza)  due  to  the  potential  negative  economic  impacts  that  may  ensue.  Although 
phylodynamics is currently encumbered by the aforementioned factors, there is hope for progress. 
Advancements in coalescent theory will help us to deal with the phylogeny construction problems 
caused by recombination and reassortment. They will also facilitate better utilization of genomic and 
spatial  data,  provided  these  advancements  are  also  accompanied  by  a  simultaneous  increase  in 
computing power, which is also currently limiting. 
Inferring Host Population Structure and Recent Demography from Viruses  
The  utility  of  phylodynamics  is  not  limited  to  questions  of  interest  to  virologists  and  disease 
ecologists. This approach may also inform investigations of host population biology and, in so doing, 
aid  in  the  development  of  conservation  policy.  Host  molecular  markers  (e.g.,  microsatellites, 
mitochondrial DNA) are used by conservation biologists and ecologists to infer population structure, 
historical  demography  and  other  critical  features  of  wildlife  populations  [52]  and  have  proved 
particularly powerful when analyzed in combination (i.e., [53,54]). Recently, it has been demonstrated 
that the pathogens of host populations might also be useful to this end. Research using helminths and 
bacteria has revealed patterns of ancient human migration and dispersal  [55,56] identified ancient 
refuges of rodent and bird taxa [57,58] and shown that there was past contact between contemporary 
non-sympatric bat species [59]. However, there have been few attempts to utilize viruses to this end 
(save [60,61]). 
It is surprising that viruses have not been used more for the inference of host population biology 
since some of their characteristics make them ideal for doing so. Most viruses have large population 
sizes and short generation times, and many replicate using a highly error-prone RNA-dependent RNA 
polymerase, causing them to accumulate many more mutations (nucleotide changes) per unit time than 
the host genomes [39,62]. Consequently, viruses may provide information about host demographics on 
a shorter timescale than molecular markers of the host. One of the signature tools of phylodynamics, 
the Bayesian skyline plot, might also be utilized to infer changes in historical population size of the 
host. These plots incorporate the use of a molecular clock and coalescent theory to infer historical 
changes  in  virus  population  sizes  without  assuming  a  predefined  demographic  model  [63].  It  is Viruses 2011, 3                         
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important, however, that the timescale over which the evolutionary dynamics of the virus population 
can be reliably reconstructed is appropriate for the parameters of interest in the host population. 
Unfortunately,  the  very  characteristics  that  make  viruses  useful  for  estimating  host  population 
structure and demography may also impede the analyses. Multiple substitutions can occur quickly in 
the viral genome and this will obscure the host population‘s actual evolutionary history. Meanwhile, 
variations in the transmission mechanisms of viruses (vertical vs. horizontal) can alter the ability to 
accurately  infer  a  virus‘  relationship  to  a  host  population.  Cross-species  transmission  is  also 
problematic in that it can cause pathogen phylogenies to inaccurately reflect the history of their hosts 
[62]. Therefore, before the genetic information contained within a virus population can be used to infer 
the  population  structure  and  demography  of  the  host,  it  is  critical  to  test  for  congruence  in  the 
evolutionary history of the host and virus populations. This is accomplished by statistically comparing 
the respective phylogenies within the relevant timescale. Viruses with high host specificity have a 
greater likelihood of exhibiting such congruence. 
Feline immunodeficiency virus (FIV) is known for high host specificity and is, thus far, the only 
virus to have been used to elucidate changes in host population structure and size. From a phylogenetic 
analysis of FIVpco, the FIV type specific to the cougar (Puma concolor), Biek, Drummond, and Poss 
(2006) [61] inferred that the North American population of cougars became subdivided during the last 
century but subsequently expanded in both size and range. Subsequently, Antunes et al. (2008) [60] 
used the distribution of FIVPle subtypes in the Serengeti to infer that recent admixture has occurred 
between the region‘s lion (Panthera leo) populations. These recent changes in felid population size 
and structure could not have been inferred from host genetic data. 
There  is  great  potential  for  the  further  use  of  this  technique  by  conservation  biologists  and 
ecologists, and for it to complement existing methods which utilize host genetic data. Host genetic 
markers  are  used  to  define  management  units  for  conservation  purposes  [64].  Many  ‗flagship‘ 
endangered species have long life histories [65], a feature that correlates with both extinction risk in 
certain  regions  [66]  and  difficulty  in  reconstructing  recent  demographic  history  from  molecular 
markers.  Because  of  the  latter,  the  use  of  viral  genetics  to  define  management  units  may  be  an 
important avenue of exploration. In addition to aiding the definition of management units, viral data 
could be used to analyze the consequences of management activities and other environmental changes 
on target species. Where viral genetic diversity exists in a spatially heterogeneous distribution, viral 
movement patterns could be used to study the migratory behavior of animals (as macroparasites have 
been [67,68]). As such, researchers could monitor the use of wildlife corridors and the efficacy of 
control measures aimed at limiting the range of a host species [69,70]. Where viruses can be readily 
amplified from non-invasively collected samples (see [71]), the above objectives could be achieved in 
a  cost  effective  manner  with  minimal  disturbance  of  the  study  species.  Viruses  with  specific 
transmission  routes  may  also  serve  as  proxies  for  behaviors  related to transmission (i.e., sexually 
transmitted diseases). Similarly, where cross-species transmission occurs, viruses might be indicative 
of  types  of  sustained,  direct  contact  between  different,  sympatric  taxa  which  facilitate  such 
transmission, for example predator-prey interactions [72]. At the broader ecosystem level, inferences 
about  long-term  evolutionary  processes  might  also  be  made  by  examining  the  phylogeographic 
structure of numerous host and virus populations of a region (see [73]).  
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3. Viral Discovery and Metagenomics 
A major hurdle for both virologists and ecologists is defining the biodiversity of life. At present, 
scientists do not know the actual number of mammal species, much less the diversity of viruses they 
harbor [2]. Indeed, the diversity of viruses known to infect the house mouse (Mus musculus), a staple 
in biomedical research, is not yet completely known. Recent advances in genetic sequencing, including 
high-throughput sequencing and other ―next-generation sequencing‖ techniques, as well as MassTag 
PCR and microarray multiplex assays [74,75] have made the study of microbial diversity feasible [76]. 
These  technologies  have  facilitated  a  movement  from  classical  virology,  where  the  focus  was  on 
disease  etiology,  toward  a  broader  discipline  that  considers  the  rest  of  the  viral  diversity  or 
―the virosphere‖.  
Metagenomic studies have used next-generation sequencing to study biodiversity in substrates such 
as ocean water and soil [77,78]. Metagenomics has also been used to screen human and animal clinical 
samples in order to determine etiologic agents of disease or to describe the microbial flora normally 
present in a vertebrate host—in many cases the result has been the discovery both of novel pathogens 
and  novel  associations  between  clinical  disease  and  agent  [79–82].  As  technology  becomes  more 
affordable, and thus accessible, there will be increasing opportunities to ask large-scale questions such 
as: How does the virosphere vary across space and time? How does it vary across species? Can we use 
this to define risk of cross-species transmission or to inform conservation efforts? And how might  
co-infections with these undiscovered viruses influence the dynamics of the more well known viruses?  
The paucity of information about viral diversity within a host poses problems for research progress. 
It is difficult to understand viral pathogenesis and transmission without completely understanding the 
dynamics of co-infections. Indeed, it is currently difficult to ascribe a host‘s symptoms to an individual 
virus with any certainty because a virus‘ actions, and even its ability to infect the host, could be a 
function of another (possibly undetected) co-habitant of the host. Evidence of interactions between  
co-infecting  species  has  been  clearly  demonstrated  [83,84]  and  it  will  be  critically  important  to 
elucidate the interactions that occur between multiple pathogens as well as the combined effects they 
may have on a host‘s immune system. Broadening our understanding of the diversity of pathogens that 
exist in human and animal hosts through wildlife and domestic animal surveillance will significantly 
improve  our  ability  to  recognize  novel  zoonotic  agents  in  the  context  of  a  disease  outbreak. 
Phylogenetic  information  obtained  from  comparative  sequence  analyses  can  improve  our 
understanding of the impact of sequence mutation on virulence, as well as inform decisions about 
vaccine development. A final noteworthy benefit of viral discovery efforts is that these techniques 
should be important for identifying candidates for future vaccines as a virus‘s most worthy competitor 
is often another virus. 
4. Vaccination 
From a health perspective, vaccination is arguably the most important technology that has arisen 
from the study of viruses. Vaccination offers a direct means of intervening in a host-pathogen system 
and  it  has  become  routine  in  many  parts  of  the  world.  Efforts  to  this  end  have  resulted  in  the 
eradication and/or control of smallpox, polio, mumps, measles, rubella and most recently, rinderpest.  Viruses 2011, 3                         
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Vaccines  take  several  forms  including  live-attenuated  viruses;  inactivated  whole  viruses; 
inactivated toxins  and  viral protein subunits, and these are often delivered in combination. While  
live-attenuated  vaccines  have  been  predominant,  a  new  generation  of  techniques  including  gene 
delivery and nano-technologies are being used to develop highly-efficacious and safer vaccines, that 
have less risk of reversion [85]. New types of administration methods are also being developed with 
oral,  aerosolized  and  nasal  vaccines  currently  on  the  market.  These  less  invasive  administration 
techniques  decrease  labor  costs  associated  with  administration  and  offer  increased  capacity  for  
mass-dispersal of vaccines to both humans and free-ranging wildlife [86]. 
Vaccination campaigns aimed at both protecting threatened species and decreasing public health 
risks via animal vaccination have taken place. Swiss health officials were pioneers in this field, using 
oral vaccines to control rabies in wild red foxes (Vulpes vulpes) [87,88]. These vaccines were inserted 
into chicken heads which were distributed in the wild beginning in 1978 [88]. As can be observed 
from  the  supplemental  movie  (Video  S1),  their  initial  barrier  approach  evolved  into a  large-scale 
treatment  of  infected  areas  and  resulted  in  rabies  being  successfully  pushed  back  to  and  then 
eliminated  from  the  Swiss  Alps  [87,88].  Following  the  success  of  these  trials,  campaigns  were 
conducted in Western Europe [89] and Canada [90] with similar results, though the situation in the 
United States has proven more challenging. Other successful vaccination examples include canine 
distemper virus in black-footed ferrets (Mustela nigripes; [91]) and Ethiopian wolves (Canis simensis; 
[92]), as well as rabies in Florida panthers (Felis concolor coryi; [93]) and African wild dogs [94,95]. 
A caveat to this success is that there is growing evidence that vaccination against a specific strain of 
pathogen  can  result  in  inadvertent  selection  for  related  co-infecting  strains.  Thus  vaccination  can 
influence the dynamics of a pathogen [96].  
The possibility of inadvertent viral strain selection highlights the importance of understanding the 
long-term  evolutionary  and  ecological  consequences  of  vaccination.  Indeed,  where  threatened  or 
endangered  animals  are  concerned,  mishaps  may  prove  disastrous.  Attenuated  canine  distemper 
vaccines did not provide immunity to critically endangered black-footed ferrets, while the use of a live 
canine  distemper  virus  vaccine resulted  in  clinical distemper arising in  one  of the few remaining 
populations  [97].  Ideally,  long-term  clinical  trials  with  suitable  animal  models  might  avert  these 
problems. These trials should also be used to provide an a priori understanding of how vaccination 
might  shape  future  evolutionary  processes.  In  contrast  to  the  ferret  experience,  efforts  with  the 
endangered Ethiopian wolf serve as an example of a successful vaccination program. Wolf populations 
were suffering severe mortality due to rabies and distemper acquired from the wild dogs that shared 
their home range [98]. On the basis of a spatially explicit individual-based model, which indicated 
rabies could be controlled in dogs given just over 60% coverage  [99], Knobel et al. executed an 
intensive vaccination plan [92]. Both the extent and duration of outbreaks in the treated areas were 
limited and, although monitoring and continued vaccination are required, the situation appeared to be 
under control in 2008 [92].  
Wildlife vaccination campaigns are also being investigated as tools to limit public health risks.  
Tsao et al. vaccinated mice in an effort to break the cycle of Lyme disease and reduce the risk of 
emergence in human populations, in which it causes tens of thousands of deaths per year in the US 
[59,100]. In the same vein, Griffing et al. [101] have tested the efficacy of vaccinating American 
robins to interrupt the WNV transmission cycle. This species can absorb up to 75% of the potentially Viruses 2011, 3                         
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infective mosquito bites in early spring and is thus a key host in the WNV system [102]. Targeted 
vaccination of this single species could potentially result in herd immunity and reduce the risk of 
human  infection  as  well  as  decreasing  wildlife  mortality.  These  works  exemplify  how  ecological 
knowledge can be used to identify and exploit some of the heterogeneities which so often dominate the 
dynamics of pathogens.  
While the lasting efficacy of wildlife vaccination efforts has yet to be demonstrated with either 
endangered species or in breaking the transmission cycle of human pathogens, an increasing number of 
researchers  are  drawing attention to  systems  where  it seems  feasible  [99,103]; demonstrating that 
intricate knowledge of host and virus ecology can greatly reduce the amount of vaccine coverage that 
is necessary to control these viruses. 
The problems entailed by the sheer number of viruses, viral resistance, the explosive potential for 
spread, and the economic burden, make it clear that currently available vaccination methods do not 
provide a sustainable solution for either human or animal disease. The unambiguous indication is that 
researchers need to work towards the goal of developing a predictive framework where risk can be 
defined for different scenarios and not only to rank pathogens, and species, but also, places and times 
of year that can be identified as more or less precarious for global health. Pending questions include: 
Which geographic areas will experience more disease and conservation problems? Which areas pose 
the highest risk for pandemic spread of pathogens? What characteristics of hosts and viruses make 
them more or less likely to be involved in cross-species transmission events? And what are the relative 
roles of genetic relatedness and contact rate for transmission? Some modeling work and reviews of 
historic data have been informative [104,105], but novel uses of phylogenies of both viruses and hosts 
(as discussed above) provide promise for progress to this end, especially when coupled with  high 
quality  surveillance data.  Once we have  this  information,  scientists  will be  able  to  design ―smart 
surveillance‖  strategies  whereby  valuable  vaccine  resources  can  be  efficiently  targeted  and 
efficiently distributed. 
5. Reservoir Host Ecology 
Ecological studies can effectively inform conservation as well as public health policy. Gaining 
knowledge of reservoir host ecology can be critical for the development of eradication strategies. Most 
viral disease systems are dominated by heterogeneities and identifying and understanding these can be 
crucially important when trying to interrupt the chain of events that leads to persistence. Ecological 
studies  of  WNV  have  shown  how  forest  fragmentation  and  decreased  biodiversity  can  alter 
transmission among avian hosts as well as to humans [106]. Likewise, researchers have used satellite 
imagery to identify habitat characteristics that accurately predict the prevalence of Sin Nombre virus 
[107,108], a hantavirus that uses the Deer mouse (Peromyscus maniculatus) as a reservoir host and it 
occasionally infects and kills humans [107]. These studies epitomize the type of effort scientists will 
need to successfully fight viral pathogens in the future. However, piecing together emerging disease 
and conservation problems ex posto facto is only of limited value. Increased pathogen surveillance and 
ecosystem process monitoring may provide the insight necessary to mitigate problems before they 
become serious human health or conservation concerns. This is especially the case for zoonotic viral 
pathogens where the reservoir hosts are known and a targeted approach is feasible. Viruses 2011, 3                         
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Rodents  rank  as  the  number  one  reservoir  of  emerging  and  re-emerging  zoonotic  viruses  [9]. 
Conveniently, these small mammals also present a manageable system for studying disease dynamics 
[109–111]. Individuals can be marked and sampled individually through time. Their locations as well 
as their contacts with other individuals can be measured. As such, wild populations of rodents can be 
valuable  as  model  disease  systems  to  address  relevant  questions  like:  Are  there  key  hosts  for 
transmission? How does prevalence vary seasonally or over time? What is the contact rate between the 
reservoir and humans? How do these pathogens flow through populations? The answers are of critical 
importance because they provide an indication of when and where there is increased risk of a zoonotic 
event whereby a human becomes infected, or when a species becomes at genuine risk of extinction. By 
monitoring and manipulating wild populations, one might also be able to identify factors that may 
increase a pathogens chance of emerging. For instance, what characteristics of hosts and viruses make 
them more or less likely to be involved in cross-species transmission? And what are the relative roles 
of genetic relatedness and contact rate for transmission? Long-term monitoring and surveillance in 
reservoirs  will  also  enlighten  us  to  the  kind  of  aggregations  and  other  heterogeneities  that  exist 
through time and that and can be exploited with efficient vaccination campaigns.  
6. Conclusion 
We are experiencing a global increase in the rate of emerging viral zoonoses, which are primarily 
driven by anthropogenic activities such as land-use change, agricultural intensification, and driven by 
global travel and trade [112]. In order to adequately understand, predict and ultimately interrupt the 
processes by which zoonoses cross the species barrier from their natural reservoirs to humans, and 
then become established as human pathogens, comprehensive scientific studies that use the tools of 
ecology, virology, microbiology, and epidemiology are needed [113]. The study of disease ecology has 
become an established discipline with advances in both the formulation of new theory as well as the 
integration  of  molecular  virological  techniques  that  provide  important  information  about 
epidemiology,  ecology  and  viral  evolution,  all  of  which  has  been  applied  to  both  health  and 
conservation  [114–116].  Because  ecological  systems  are  rife  with  heterogeneities  and  often  have  
non-intuitive  processes  underlying  their  dynamics,  it  is  critically  important  for  scientists  to  use  a 
comprehensive approach to understanding the population processes of an ecosystem before successful 
intervention strategies can be developed or implemented. Admittedly this is a daunting task and it is 
often the case that scientists need to operate with less than complete information. Where this is the 
case, a modeling approach is necessary to identify key processes that allow successful interventions. 
Technological  advances  in  molecular  virology  and  genetics,  as  well  as  the  expanded  use  of 
mathematical models in epidemiology and disease ecology have dramatically changed our ability to 
manage both conservation and health. Finally, it is only with this type of interdisciplinary approach 
that considers free-ranging wildlife, domestic animals and humans as inextricable components of a 
single disease system, that progress can be made that will satisfy both conservation and public health 
needs. This is the essence of conservation medicine [117] and indeed we believe a ―One Health‖ 
approach to infectious disease is necessarily the way forward.  Viruses 2011, 3                         
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